MedPath

IMPACT OF SWALLOWING THERAPY IN MANAGEMENT OF DYSPHAGIA POST RADIOTHERAPY

Phase 2
Conditions
Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
Registration Number
CTRI/2020/04/024828
Lead Sponsor
PGIMER CHANDIGARH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

a)Biopsy proven oropharyngeal, hypopharyngeal and oral cavity cancers

b)Stage III - IV disease treated with radical intent

c)Karnofsky performance scale > 70

d)Patients giving written consent to be part of study

Exclusion Criteria

a)Metastatic disease

b)Post operative cases

c)Patients with pre existing swallowing disorders or neurological disorders interfering with swallowing.

d)Previously treated patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)To document the baseline and treatment related dysphagia in patients under study <br/ ><br>2)To evaluate the impact of swallowing therapy on incidence and grade of dysphagia between the study groupsTimepoint: BASELINE, 1,3 AND 6 MONTHS POST RT
Secondary Outcome Measures
NameTimeMethod
To evaluate the quality of life with and without swallowing therapy between the two study groups.Timepoint: BASELINE, 1,3 AND 6 MONTHS POST RT
© Copyright 2025. All Rights Reserved by MedPath